Annual CFF
-$907.00 K
+$2.36 M+72.24%
December 31, 2023
Summary
- As of March 6, 2025, CASI annual cash flow from financing activities is -$907.00 thousand, with the most recent change of +$2.36 million (+72.24%) on December 31, 2023.
- During the last 3 years, CASI annual CFF has fallen by -$48.06 million (-101.92%).
- CASI annual CFF is now -100.98% below its all-time high of $92.27 million, reached on December 31, 2018.
Performance
CASI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
N/A
September 1, 2024
Summary
- CASI quarterly cash flow from financing activities is not available.
Performance
CASI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
N/A
September 1, 2024
Summary
- CASI TTM cash flow from financing activities is not available.
Performance
CASI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CASI Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +72.2% | - | - |
3 y3 years | -101.9% | - | - |
5 y5 years | -101.0% | - | - |
CASI Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -103.1% | +72.2% | ||||
5 y | 5-year | -101.9% | +72.2% | ||||
alltime | all time | -101.0% | +88.3% |
CASI Pharmaceuticals Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | -$907.00 K(-72.2%) | - | - |
Dec 2022 | -$3.27 M(-111.0%) | -$3.27 M(-263.4%) | -$3.27 M(+201.1%) |
Sep 2022 | - | $2.00 M(+99.7%) | -$1.08 M(-69.4%) |
Jun 2022 | - | $1.00 M(-133.4%) | -$3.55 M(-22.0%) |
Mar 2022 | - | -$3.00 M(+176.5%) | -$4.55 M(-115.3%) |
Dec 2021 | $29.64 M(-37.1%) | -$1.08 M(+134.3%) | $29.64 M(-5.9%) |
Sep 2021 | - | -$463.00 K(<-9900.0%) | $31.49 M(-56.8%) |
Jun 2021 | - | $0.00(-100.0%) | $72.92 M(-0.7%) |
Mar 2021 | - | $31.19 M(+3977.1%) | $73.41 M(+55.7%) |
Dec 2020 | $47.15 M(+113.9%) | $765.00 K(-98.1%) | $47.15 M(-2.9%) |
Sep 2020 | - | $40.96 M(+8328.8%) | $48.54 M(+618.7%) |
Jun 2020 | - | $486.00 K(-90.2%) | $6.75 M(+7.7%) |
Mar 2020 | - | $4.94 M(+129.5%) | $6.27 M(-71.6%) |
Dec 2019 | $22.05 M(-76.1%) | $2.15 M(-361.8%) | $22.05 M(-2.9%) |
Sep 2019 | - | -$822.00 K(<-9900.0%) | $22.70 M(-62.8%) |
Jun 2019 | - | $1000.00(-100.0%) | $61.06 M(-25.8%) |
Mar 2019 | - | $20.71 M(+637.9%) | $82.33 M(-10.8%) |
Dec 2018 | $92.27 M(+288.8%) | $2.81 M(-92.5%) | $92.27 M(-18.5%) |
Sep 2018 | - | $37.54 M(+76.4%) | $113.20 M(+49.6%) |
Jun 2018 | - | $21.28 M(-30.6%) | $75.66 M(+39.1%) |
Mar 2018 | - | $30.65 M(+29.1%) | $54.38 M(+129.1%) |
Dec 2017 | $23.73 M(-15.4%) | $23.73 M(>+9900.0%) | $23.73 M(+416.7%) |
Sep 2017 | - | $0.00(0.0%) | $4.59 M(-61.3%) |
Jun 2017 | - | $0.00(0.0%) | $11.87 M(-33.4%) |
Mar 2017 | - | $0.00(-100.0%) | $17.83 M(-36.4%) |
Dec 2016 | $28.05 M(>+9900.0%) | $4.59 M(-36.9%) | $28.05 M(+19.6%) |
Sep 2016 | - | $7.28 M(+22.3%) | $23.46 M(+45.0%) |
Jun 2016 | - | $5.95 M(-41.8%) | $16.18 M(+58.2%) |
Mar 2016 | - | $10.22 M(>+9900.0%) | $10.22 M(>+9900.0%) |
Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
Jun 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2015 | - | $0.00(0.0%) | $0.00(-100.0%) |
Dec 2013 | $10.40 M(+12.7%) | $0.00(-100.0%) | $10.40 M(0.0%) |
Sep 2013 | - | $24.30 K(+1004.5%) | $10.40 M(+0.4%) |
Jun 2013 | - | $2200.00(-100.0%) | $10.36 M(+0.7%) |
Mar 2013 | - | $10.37 M(>+9900.0%) | $10.29 M(+11.4%) |
Dec 2012 | $9.23 M(+2268.9%) | $0.00(-100.0%) | $9.23 M(0.0%) |
Sep 2012 | - | -$16.60 K(-77.0%) | $9.23 M(+0.1%) |
Jun 2012 | - | -$72.30 K(-100.8%) | $9.22 M(-10.5%) |
Mar 2012 | - | $9.32 M(>+9900.0%) | $10.31 M(+2544.7%) |
Dec 2011 | $389.60 K(-89.0%) | $0.00(-100.0%) | $389.70 K(-121.1%) |
Sep 2011 | - | -$24.60 K(-102.4%) | -$1.85 M(-352.1%) |
Jun 2011 | - | $1.01 M(-269.2%) | $732.70 K(+119.4%) |
Mar 2011 | - | -$598.80 K(-73.2%) | $334.00 K(-90.6%) |
Dec 2010 | $3.54 M(-145.8%) | -$2.24 M(-187.5%) | $3.54 M(-6.2%) |
Sep 2010 | - | $2.56 M(+315.9%) | $3.77 M(-608.3%) |
Jun 2010 | - | $614.40 K(-76.4%) | -$741.50 K(-77.3%) |
Mar 2010 | - | $2.60 M(-229.9%) | -$3.26 M(-57.7%) |
Dec 2009 | -$7.72 M(+152.4%) | -$2.00 M(+2.4%) | -$7.72 M(+2.6%) |
Sep 2009 | - | -$1.96 M(+2.5%) | -$7.52 M(+10.9%) |
Jun 2009 | - | -$1.91 M(+2.9%) | -$6.78 M(+38.1%) |
Mar 2009 | - | -$1.85 M(+2.4%) | -$4.91 M(+60.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2008 | -$3.06 M(-115.5%) | -$1.81 M(+49.1%) | -$3.06 M(+390.9%) |
Sep 2008 | - | -$1.21 M(+3260.1%) | -$622.90 K(-103.1%) |
Jun 2008 | - | -$36.10 K(<-9900.0%) | $20.05 M(+0.4%) |
Mar 2008 | - | $0.00(-100.0%) | $19.97 M(+1.1%) |
Dec 2007 | $19.75 M(-54.3%) | $626.20 K(-96.8%) | $19.75 M(-43.3%) |
Sep 2007 | - | $19.46 M(<-9900.0%) | $34.83 M(+129.5%) |
Jun 2007 | - | -$123.10 K(-43.8%) | $15.18 M(+0.9%) |
Mar 2007 | - | -$219.00 K(-101.4%) | $15.04 M(-65.2%) |
Dec 2006 | $43.21 M(+336.3%) | $15.71 M(-8162.0%) | $43.21 M(+57.1%) |
Sep 2006 | - | -$194.90 K(-25.0%) | $27.50 M(-0.7%) |
Jun 2006 | - | -$259.90 K(-100.9%) | $27.69 M(-0.7%) |
Mar 2006 | - | $27.95 M(<-9900.0%) | $27.88 M(+181.5%) |
Dec 2005 | $9.90 M(-25.5%) | -$600.00(-200.0%) | $9.90 M(-57.3%) |
Sep 2005 | - | $600.00(-100.8%) | $23.20 M(+0.0%) |
Jun 2005 | - | -$73.60 K(-100.7%) | $23.20 M(-0.3%) |
Mar 2005 | - | $9.98 M(-24.9%) | $23.27 M(+75.1%) |
Dec 2004 | $13.29 M(-64.9%) | $13.29 M(>+9900.0%) | $13.29 M(-32.1%) |
Sep 2004 | - | $0.00(0.0%) | $19.58 M(-0.0%) |
Jun 2004 | - | $0.00(0.0%) | $19.58 M(-46.8%) |
Mar 2004 | - | $0.00(-100.0%) | $36.80 M(-2.8%) |
Dec 2003 | $37.84 M(+46.5%) | $19.58 M(>+9900.0%) | $37.84 M(-0.5%) |
Sep 2003 | - | $900.00(-100.0%) | $38.02 M(+0.7%) |
Jun 2003 | - | $17.21 M(+1551.9%) | $37.75 M(+77.0%) |
Mar 2003 | - | $1.04 M(-94.7%) | $21.33 M(-17.4%) |
Dec 2002 | $25.83 M(-46.6%) | $19.77 M(-7203.6%) | $25.83 M(-3.9%) |
Sep 2002 | - | -$278.30 K(-135.0%) | $26.89 M(+0.2%) |
Jun 2002 | - | $794.70 K(-85.7%) | $26.82 M(+3.9%) |
Mar 2002 | - | $5.55 M(-73.4%) | $25.82 M(-46.6%) |
Dec 2001 | $48.33 M(+8.9%) | $20.82 M(-6200.9%) | $48.33 M(+104.8%) |
Sep 2001 | - | -$341.30 K(+66.3%) | $23.60 M(-1.7%) |
Jun 2001 | - | -$205.20 K(-100.7%) | $24.00 M(-57.4%) |
Mar 2001 | - | $28.06 M(-818.3%) | $56.36 M(+27.0%) |
Dec 2000 | $44.36 M(+55.1%) | -$3.91 M(-7149.8%) | $44.36 M(-6.9%) |
Sep 2000 | - | $55.40 K(-99.8%) | $47.67 M(-37.6%) |
Jun 2000 | - | $32.16 M(+100.2%) | $76.42 M(+71.9%) |
Mar 2000 | - | $16.06 M(-2776.4%) | $44.45 M(+55.4%) |
Dec 1999 | $28.60 M(+508.5%) | -$600.00 K(-102.1%) | $28.60 M(-6.5%) |
Sep 1999 | - | $28.80 M(>+9900.0%) | $30.60 M(+1078.5%) |
Jun 1999 | - | $189.20 K(-8.8%) | $2.60 M(-43.6%) |
Mar 1999 | - | $207.40 K(-85.2%) | $4.61 M(-2.0%) |
Dec 1998 | $4.70 M(+1075.0%) | $1.40 M(+75.0%) | $4.70 M(+42.4%) |
Sep 1998 | - | $800.00 K(-63.6%) | $3.30 M(+26.9%) |
Jun 1998 | - | $2.20 M(+633.3%) | $2.60 M(+333.3%) |
Mar 1998 | - | $300.00 K(>+9900.0%) | $600.00 K(+50.0%) |
Dec 1997 | $400.00 K(-99.2%) | $0.00(-100.0%) | $400.00 K(0.0%) |
Sep 1997 | - | $100.00 K(-50.0%) | $400.00 K(+100.0%) |
Jun 1997 | - | $200.00 K(+100.0%) | $200.00 K(-99.6%) |
Mar 1997 | - | $100.00 K(>+9900.0%) | $46.70 M(-3.5%) |
Dec 1996 | $48.40 M | $0.00(-100.0%) | $48.40 M(0.0%) |
Sep 1996 | - | -$100.00 K(-100.2%) | $48.40 M(-0.2%) |
Jun 1996 | - | $46.70 M(+2494.4%) | $48.50 M(+2594.4%) |
Mar 1996 | - | $1.80 M | $1.80 M |
FAQ
- What is CASI Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual CFF year-on-year change?
- What is the all time high quarterly CFF for CASI Pharmaceuticals?
- What is the all time high TTM CFF for CASI Pharmaceuticals?
What is CASI Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of CASI is -$907.00 K
What is the all time high annual CFF for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual cash flow from financing activities is $92.27 M
What is CASI Pharmaceuticals annual CFF year-on-year change?
Over the past year, CASI annual cash flow from financing activities has changed by +$2.36 M (+72.24%)
What is the all time high quarterly CFF for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly cash flow from financing activities is $46.70 M
What is the all time high TTM CFF for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high TTM cash flow from financing activities is $113.20 M